Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Collins

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|September 1, 2004
Self-incompatibility genotypes in almond re-evaluated by PCR, stylar ribonucleases, sequencing analysis and controlled pollinationsMercè López, Mourad Mnejja, Mercè Rovira, et al.
Journal of Clinical Medicine|July 15, 2026
Pleural Management Pathways and Outcomes in Haematological Malignancy-Associated Malignant Pleural EffusionOlivia Walsh, Alguili Elshekih, Dinesh Addala, et al.
Journal of Virological Methods|November 6, 2003
Comparison of ELISA and RT-PCR for the detection of Prunus necrotic ring spot virus and prune dwarf virus in almond (Prunus dulcis)Genet Mekuria, Sunita A Ramesh, Evita Alberts, et al.
International Journal of Particle Therapy|May 9, 2022
Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin LymphomaAshley Way, Savas Ozdemir, Barbara Berges, et al.
Haematologica|June 14, 2006
The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomasJennifer C Paterson, Sara Tedoldi, Andrew Craxton, et al.
British Journal of Haematology|November 12, 2019
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012)William Townsend, Sarah Leong, Peter Hoskin, et al.
F1000Research|October 23, 2020
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trialAndrew Davies, Sharon Barrans, Cathy Burton, et al.
Leukemia & Lymphoma|August 27, 2020
Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapyDavid Straus, Graham Collins, Jan Walewski, et al.
Circulation. Heart Failure|June 29, 2022
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline CardiotoxicityPeter A Henriksen, Peter Hall, Olga Oikonomidou, et al.
The Lancet. Oncology|July 25, 2016
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trialAnas Younes, Armando Santoro, Margaret Shipp, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|September 1, 2004
Self-incompatibility genotypes in almond re-evaluated by PCR, stylar ribonucleases, sequencing analysis and controlled pollinationsMercè López, Mourad Mnejja, Mercè Rovira, et al.
Journal of Clinical Medicine|July 15, 2026
Pleural Management Pathways and Outcomes in Haematological Malignancy-Associated Malignant Pleural EffusionOlivia Walsh, Alguili Elshekih, Dinesh Addala, et al.
Journal of Virological Methods|November 6, 2003
Comparison of ELISA and RT-PCR for the detection of Prunus necrotic ring spot virus and prune dwarf virus in almond (Prunus dulcis)Genet Mekuria, Sunita A Ramesh, Evita Alberts, et al.
International Journal of Particle Therapy|May 9, 2022
Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin LymphomaAshley Way, Savas Ozdemir, Barbara Berges, et al.
Haematologica|June 14, 2006
The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomasJennifer C Paterson, Sara Tedoldi, Andrew Craxton, et al.
British Journal of Haematology|November 12, 2019
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012)William Townsend, Sarah Leong, Peter Hoskin, et al.
F1000Research|October 23, 2020
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trialAndrew Davies, Sharon Barrans, Cathy Burton, et al.
Leukemia & Lymphoma|August 27, 2020
Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapyDavid Straus, Graham Collins, Jan Walewski, et al.
Circulation. Heart Failure|June 29, 2022
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline CardiotoxicityPeter A Henriksen, Peter Hall, Olga Oikonomidou, et al.
The Lancet. Oncology|July 25, 2016
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trialAnas Younes, Armando Santoro, Margaret Shipp, et al.
Pageof 3